Adams Street Partners LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 14, 2025), Adams Street Partners LLC reported 7 stock positions worth $113.0 million. Its top holding was Rimini Street (RMNI) at 72.6% of the portfolio, followed by Palvella Therapeutics (PVLA, 10.2%) and Corvus Pharmaceuticals (CRVS, 9.2%). Compared with Q4 2024, it opened 2 new positions, sold out of 1 and reduced 1. The biggest buy was a new position in Kanzhun Ltd. - ADR (BZ) and the biggest sale an exit from Mineralys Therapeutics (MLYS).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001193586
- Portfolio Value
- $113.0M (Q1 2025)
- SEC Filing
- 0001104659-25-048414 ↗ filed May 14, 2025
Holdings Value
Holdings 7 stocks · $113.0M
| RMNI Rimini Street Inc. | 72.60% | 23,565,433 | $82.0M | No change |
| PVLA Palvella Therapeutics Inc. | 10.15% | 409,666 | $11.5M | No change |
| CRVS Corvus Pharmaceuticals Inc. | 9.22% | 3,275,616 | $10.4M | No change |
| VACASA INC | 4.47% | 938,221 | $5.0M | No change |
| PAY Paymentus Holdings Inc. Class A | 1.69% | 72,968 | $1.9M | Reduce -73.4% |
| BZ Kanzhun Ltd. - ADR | 1.48% | 87,157 | $1.7M | New |
| TEM Tempus AI Inc. Class A | 0.40% | 9,266 | $447K | New |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $442.7M | BLLN, RMNI, CBRS, CRVS |
| Q1 2026 | 3 | $260.3M | BLLN, RMNI, CRVS |
| Q4 2025 | 5 | $263.9M | BLLN, RMNI, CRVS, PAY, CAI |
| Q3 2025 | 5 | $153.2M | RMNI, CRVS, PGY, IOT, PAY |
| Q2 2025 | 6 | $142.0M | RMNI, IOT, CRVS, PAY, PVLA |
| Q1 2025 | 7 | $113.0M | RMNI, PVLA, CRVS, VACASA INC, PAY |
| Q4 2024 | 6 | $112.8M | RMNI, CRVS, MLYS, PAY, PVLA |
| Q3 2024 | 6 | $181.7M | PCTY, RMNI, QTWO, MLYS, CRVS |
| Q2 2024 | 9 | $242.7M | RMNI, PCTY, PDD, QTWO, MLYS |
| Q1 2024 | 12 | $251.7M | PCTY, RMNI, QTWO, MLYS, COIN |